Article
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
March Social Media Round-Up—Annual Review, International Women’s Day, and a School of Science Celebration
March is an eventful month, with the launch of spring, the changing of the clocks, St. Patrick’s Day, and more. Here at Pfizer, we had plenty occasions to mark, and all month long our leadership did just that, sharing their thoughts on International Women’s Day and Employee Appreciation Day, celebrating the anniversary of our School of Science, and looking back at our recent accomplishments with the publication of our Annual Review.Hear from our leaders themselves with our monthly social media...
Working to “Outdo” Cancer: A Multi-Modality Approach to Accelerating the Next Generation of Cancer Breakthroughs
If you caught Pfizer’s exciting commercial that ran during the NFL’s big game in February, you know that we are making a renewed commitment to outdo cancer – nothing is more urgent, or more personal, than our goal to outpace, outsmart, and outmaneuver cancer at every turn. We’re marshaling resources, making new partnerships, and investing in the fight against the many forms of the disease to help people with cancer live longer and better lives. But it won’t be easy.Cancer cells are extremely...
Pfizer Celebrates Legacy, Justice, and Equity
Pfizer colleagues reflected on the significance of the Martin Luther King, Jr holiday and Black History Month with a series of events organized by members of Pfizer’s Global Black Community (GBC). These events, which included discussions, panels, and community-based gatherings, embraced the legacy of Dr. Martin Luther King Jr., and paid tribute to those who have helped shape the past, present, and future of the Black community, guided by principles of justice, equity, and inclusion.The...
2023 In Review
At Pfizer, we are working tirelessly to outdo yesterday by bringing new breakthroughs to patients around the globe in innovative ways. As we do this, it’s important that we take the time to reflect on both our challenges and our achievements. Every March, we share those reflections with the public via our Annual Review and Impact Report. In this year’s reports, we look at the numbers behind the breakthroughs and explore the tangible ways that we pushed science forward in service of patients...
February Social Media Round-Up—Outdoing Cancer, Celebrating 175, and Hopping on a TikTok Trend
The year’s shortest month didn’t feel like it, at least not if you’re part of Pfizer. From our commitment to outdoing cancer to a celebration of our legacy, we were loud and proud about both the celebrated past and exciting future of the company.We’ve also highlighted some noteworthy social posts from our corporate channels, including Facebook, Instagram, and TikTok. (Yes, we’re on TikTok!) Check it out, and stay tuned for more!Posts from our LeadershipCEO Albert Bourla on Pfizer’s commitment to...
Pfizer’s Statement on Results of Fifth Annual Pay Equity Study Among Colleagues Worldwide
NEW YORK, N.Y., February 23, 2024 – Pfizer Inc. (NYSE:PFE) announced today that, for the fifth consecutive year, an independent compensation expert confirmed equitable pay practices for employees at Pfizer.The study assessed pay equity for gender worldwide and for minorities in the United States based on compensation data, including base pay and bonuses. The study measured the difference between similar groups of employees when adjusting for factors such as role, grade, job level, and location.T...
January Social Media Round-Up—Celebrating 175, Discussing AI, and Attending CES 2024
One month into the new year and Pfizer is already got plenty to show for it.January’s social media round-up features a dispatch from Las Vegas’s CES conference, our CTO’s insight into artificial intelligence’s impact on cancer, and an impassioned pleas from our CEO.Catch up below:CEO Albert Bourla kicks off Pfizer’s 175th anniversary celebration:https://www.linkedin.com/posts/albert-bourla_2024-marks-a-significant-year-for-pfizer-activity-7150126029393580032-ES_A?utm_source=share&utm_medium...
Pfizer Kicks Off 175th Anniversary by Looking Back at Legacy and Ahead to the Future
Way back in 1849, Charles Pfizer and Charles Erhart started the company we know today as Pfizer, and ever since, we’ve been at the forefront of some of the most profound changes in medicine and technology. For 175 years, we have had an extraordinary impact on global health.But in many ways, we’re just getting started. Throughout 2024, we will celebrate and appreciate everything that we have accomplished while we move forward with confidence that the best is yet to come. Together, we will outdo...
“Change the Odds” Brings Pfizer Together with the American Cancer Society to Bridge the Gap in Cancer Care Disparities
Pfizer has long been committed to the research and development of innovative cancer treatments for patients around the world. This commitment was further strengthened by the addition of Seagen, a world leader in a powerful cancer-fighting tool called antibody-drug conjugates, enabling us to be at the forefront of cancer care. Additionally, addressing inequities in the healthcare of patients is one of Pfizer’s top priorities, and we’re proud to announce a new initiative that incorporates both of...
Together We Can Change the Odds for People with Cancer
One in three people in the United States will receive a cancer diagnosis in their lifetime.i This means you, or someone you know, may someday be impacted. This disease does not discriminate. Unfortunately, many people face unnecessary barriers to timely and equitable screening, treatment and support. To help close these gaps, the American Cancer Society (ACS) and Pfizer recently launched a new three-year initiative, “Change the Odds: Uniting to Improve Cancer Outcomes,” aimed at addressing...
Pfizer Presents New Cancer Research at ASCO GU Cancers Symposium
This week, from January 25-27th, Pfizer will join the genitourinary oncology community at the 20th annual meeting of the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium. As the premier professional society of clinicians and scientists dedicated to confronting prostate and urinary diseases, ASCO GU has been featuring the latest high-impact science, multidisciplinary expertise, and evidence-based practices in GU cancer care for the past two decades.A long-time...
Pfizer Awards $2M to Nonprofit Organizations Addressing Systemic Health Inequities
video-js.video-js.vjs-fluid:not(.vjs-audio-only-mode) { padding-top: 56.25%; } Equity is a core value at Pfizer, and we have a longstanding commitment to helping resolve deeply ingrained systemic health inequities. To make better health possible for everyone, everywhere, we develop programs and embark on partnerships that help educate, include, and reach communities that have been historically overlooked.One of those programs – the ‘Communities in Action for Health Equity’ grant...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.